ClinicalTrials.gov record
Not listed Phase 3 Interventional

Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

ClinicalTrials.gov ID: NCT00002659

Public ClinicalTrials.gov record NCT00002659. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFECT OF CISPLATIN/EPINEPHRINE INJECTABLE GEL (PRODUCT MPI 5010) WHEN ADMINISTERED INTRATUMORALLY FOR ACHIEVEMENT OF TREATMENT GOALS IN RECURRENT OR REFRACTORY SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK

Study identification

NCT ID
NCT00002659
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Matrix Pharmaceutical
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • cisplatin-e therapeutic implant Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 1995
Primary completion
Not listed
Completion
Not listed
Last update posted
Dec 18, 2013

Started 1995

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
24
Facility City State ZIP Site status
Veterans Affairs Medical Center - Tucson Tucson Arizona 85723
Arizona Cancer Center Tucson Arizona 85724
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-1781
Veterans Affairs Medical Center - Palo Alto Palo Alto California 94304
UCSF Cancer Center and Cancer Research Institute San Francisco California 94115-0128
Stanford University Medical Center Stanford California 94305-5408
Comprehensive Cancer Center at JFK Medical Center Atlantis Florida 33462
Sylvester Cancer Center, University of Miami Miami Florida 33136
Evanston Northwestern Health Care Evanston Illinois 60201
University of Kansas Medical Center Kansas City Kansas 66160-7357
University of Kentucky College of Medicine Lexington Kentucky 40536-0084
Louisiana State University Medical Center - New Orleans New Orleans Louisiana 70112
Louisiana State University Hospital - Shreveport Shreveport Louisiana 71130-3932
Veterans Affairs Medical Center - Baltimore Baltimore Maryland 21218
Capitol Comprehensive Cancer Care Clinic Jefferson City Missouri 65109
Washington University School of Medicine St Louis Missouri 63110
Methodist Cancer Center - Omaha Omaha Nebraska 68114
Creighton University Cancer Center Omaha Nebraska 68131-2197
University of New Mexico Cancer Research & Treatment Center Albuquerque New Mexico 87131
Oregon Cancer Center at Oregon Health Sciences University Portland Oregon 97201-3098
Palmetto Richland Memorial Hospital Columbia South Carolina 29203
Thompson Cancer Survival Center Knoxville Tennessee 37916
Boston Cancer Group Memphis Tennessee 38119
Southwest Regional Cancer Center Austin Texas 78705
University of Texas Southwestern Medical School Dallas Texas 75235-9032
Department of Otolaryngology Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00002659, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2013 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00002659 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →